We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
E-therapeutics Plc | LSE:ETX | London | Ordinary Share | GB00B2823H99 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.325 | 3.67% | 9.175 | 8.90 | 9.45 | 9.05 | 8.80 | 8.85 | 2,186,052 | 16:35:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 475k | -8.27M | -0.0142 | -6.34 | 52.55M |
TIDMETX
RNS Number : 1755H
e-Therapeutics plc
05 June 2017
For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ------------------------------------------------------------------------------------------- 1. Identity of the issuer or e-Therapeutics plc the underlying issuer of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------- ------------------------------ 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------ ----------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------ ----------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------ ----------------------------- An event changing the breakdown of voting rights ------------------------------------------------------------ ----------------------------- Other (please specify): ---------------------------------------------------------- ----------------------------- 3. Full name of person(s) Malcolm Philip Young subject to the notification obligation: (iii) ----------------------------------------------------------- ------------------------------ 4. Full name of shareholder(s) UBS Private Banking Nominees (if different from 3.):(iv) Ltd ----------------------------------------------------------- ------------------------------ 5. Date of the transaction 02/06/2017 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- ------------------------------ 6. Date on which issuer 05/06/2017 notified: ----------------------------------------------------------- ------------------------------ 7. Threshold(s) that is/are crossed or reached: (vi, vii) 8%, 7%, 6%, 5%, 4%, 3% ----------------------------------------------------------- ------------------------------ 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------- -------------------------------- -------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights -------------- --------------- --------------- ------------- -------------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ----------- ----------- ------------- ------------ ------------ ------------ ----------- Ordinary Shares GB00B2823H99 23,854,572 23,854,572 2,305,747 2,305,747 0.9% --------------- --------------- ------------- ------------ ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion rights that rights (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ------------------ ------------- ------------------------------ ---------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) ---------------- ------------- ------------- --------------- ---------------------------- ----------------------- Nominal Delta ---------------- ------------- ------------- --------------- ---------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights -------------------------------------------------- ------------------------------------------------------------------ 2,305,747 0.9% -------------------------------------------------- ------------------------------------------------------------------ 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------------------------------- Proxy Voting: --------------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ------------------------ 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ------------------------ 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ------------------------ 13. Additional information: None ------------------------------------------------------------- ------------------------ 14. Contact name: Professor Malcolm Young ------------------------------------------------------------- ------------------------ 15. Contact telephone number: 01912111010 ------------------------------------------------------------- ------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFLVRAIEIID
(END) Dow Jones Newswires
June 05, 2017 09:21 ET (13:21 GMT)
1 Year E-therapeutics Chart |
1 Month E-therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions